Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

  • The following term was not found in PubMed: editors%3a.
1.

Development of a validated method for the qualitative and quantitative analysis of cannabinoids in plant biomass and medicinal cannabis resin extracts obtained by super-critical fluid extraction.

Elkins AC, Deseo MA, Rochfort S, Ezernieks V, Spangenberg G.

J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Mar 1;1109:76-83. doi: 10.1016/j.jchromb.2019.01.027. Epub 2019 Jan 30.

PMID:
30738340
2.

Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.

Lattanzi S, Brigo F, Trinka E, Zaccara G, Cagnetti C, Del Giovane C, Silvestrini M.

Drugs. 2018 Nov;78(17):1791-1804. doi: 10.1007/s40265-018-0992-5. Review.

PMID:
30390221
3.

Marijuana's Effects on Brain Structure and Function: What Do We Know and What Should We Do? A Brief Review and Commentary.

deShazo RD, Parker SB, Williams D, Ingram JB, Elsohly M, Rodenmeyer K, McCullouch K.

Am J Med. 2019 Mar;132(3):281-285. doi: 10.1016/j.amjmed.2018.09.006. Epub 2018 Sep 18. Review.

PMID:
30240677
4.

The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next.

Rubin R.

JAMA. 2018 Sep 25;320(12):1227-1229. doi: 10.1001/jama.2018.11914. No abstract available.

PMID:
30193358
5.

Review of the neurological benefits of phytocannabinoids.

Maroon J, Bost J.

Surg Neurol Int. 2018 Apr 26;9:91. doi: 10.4103/sni.sni_45_18. eCollection 2018. Review.

6.

Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents - An observational, longitudinal study.

Hausman-Kedem M, Menascu S, Kramer U.

Brain Dev. 2018 Aug;40(7):544-551. doi: 10.1016/j.braindev.2018.03.013. Epub 2018 Apr 16.

PMID:
29674131
7.

Police probe of Brazilian marijuana researcher sparks protests.

Angelo C.

Nature. 2018 Mar 15;555(7696):296. doi: 10.1038/d41586-018-02842-0. No abstract available.

PMID:
29542710
8.

Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.

Porcari GS, Fu C, Doll ED, Carter EG, Carson RP.

Epilepsy Behav. 2018 Mar;80:240-246. doi: 10.1016/j.yebeh.2018.01.026. Epub 2018 Feb 9.

9.

Practical considerations in medical cannabis administration and dosing.

MacCallum CA, Russo EB.

Eur J Intern Med. 2018 Mar;49:12-19. doi: 10.1016/j.ejim.2018.01.004. Epub 2018 Jan 4. Review.

PMID:
29307505
10.

Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.

Rotolo MC, Graziano S, Pellegrini M, Corlazzoli D, Antinori L, Porcarelli L, Pichini S.

Curr Pharm Biotechnol. 2017;18(10):821-827. doi: 10.2174/1389201018666171122115815.

PMID:
29173160
11.

[Cannabis use in Epilepsy. Current situation in Argentina and abroad].

Kochen S.

Vertex. 2016 Nov;XXVII(130):457-462. Spanish.

PMID:
28898306
12.

Training and Practices of Cannabis Dispensary Staff.

Haug NA, Kieschnick D, Sottile JE, Babson KA, Vandrey R, Bonn-Miller MO.

Cannabis Cannabinoid Res. 2016 Dec 1;1(1):244-251. doi: 10.1089/can.2016.0024. eCollection 2016.

13.

The current status of artisanal cannabis for the treatment of epilepsy in the United States.

Sulak D, Saneto R, Goldstein B.

Epilepsy Behav. 2017 May;70(Pt B):328-333. doi: 10.1016/j.yebeh.2016.12.032. Epub 2017 Feb 21.

PMID:
28254350
14.

Cannabis cultivation: Methodological issues for obtaining medical-grade product.

Chandra S, Lata H, ElSohly MA, Walker LA, Potter D.

Epilepsy Behav. 2017 May;70(Pt B):302-312. doi: 10.1016/j.yebeh.2016.11.029. Epub 2017 Feb 13. Review.

PMID:
28202406
15.

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Rosenberg EC, Patra PH, Whalley BJ.

Epilepsy Behav. 2017 May;70(Pt B):319-327. doi: 10.1016/j.yebeh.2016.11.006. Epub 2017 Feb 9. Review.

16.

Cannabinoids in treatment-resistant epilepsy: A review.

O'Connell BK, Gloss D, Devinsky O.

Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8. Review.

PMID:
28188044
17.

The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.

Mead A.

Epilepsy Behav. 2017 May;70(Pt B):288-291. doi: 10.1016/j.yebeh.2016.11.021. Epub 2017 Feb 4. Review.

18.

Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.

Allendorfer JB, Szaflarski JP.

Epilepsy Behav. 2017 May;70(Pt B):349-354. doi: 10.1016/j.yebeh.2016.11.020. Epub 2017 Jan 18. Review.

PMID:
28109780
19.

Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.

Friedman D, Sirven JI.

Epilepsy Behav. 2017 May;70(Pt B):298-301. doi: 10.1016/j.yebeh.2016.11.033. Epub 2017 Jan 12. Review.

PMID:
28089286
20.

Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers.

Babalonis S, Haney M, Malcolm RJ, Lofwall MR, Votaw VR, Sparenborg S, Walsh SL.

Drug Alcohol Depend. 2017 Mar 1;172:9-13. doi: 10.1016/j.drugalcdep.2016.11.030. Epub 2016 Dec 14.

Supplemental Content

Loading ...
Support Center